Oxynorm (Oxycodone Hydrochloride)

Oxynorm is an opioid analgesic that acts on the central nervous system to relieve pain.

• Acute postoperative pain: provides rapid relief of pain following surgery.
• Cancer‑related pain: helps manage persistent pain associated with malignant disease.
• Chronic non‑cancer pain: reduces pain intensity in conditions such as severe osteoarthritis when other treatments have failed.

• Oxycodone hydrochloride binds to μ‑opioid receptors in the brain and spinal cord, activating inhibitory G‑protein pathways that decrease neuronal excitability and reduce the transmission of nociceptive signals, resulting in analgesia.

Adverse reactions to Oxynorm vary in frequency and severity.

Common Side Effects

• Constipation: reduced gastrointestinal motility.
• Nausea: feeling of queasiness or urge to vomit.
• Drowsiness: increased sleepiness or fatigue.
• Dry mouth: reduced salivation.
• Dizziness: light‑headed sensation.
• Sweating: increased perspiration.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing.
• Severe hypotension: marked drop in blood pressure.
• Opioid dependence or addiction: compulsive drug‑seeking behavior.
• Seizures: rare occurrence of convulsive episodes.
• Anaphylaxis: potentially life‑threatening allergic reaction.
• adrenal disorder: adrenal insufficiency, a rare endocrine abnormality.

When prescribing Oxynorm, clinicians should consider several safety factors.

• Assess pain severity and prior opioid exposure: ensure appropriate indication.
• Monitor for respiratory depression: watch for slowed breathing, especially after dose changes.
• Evaluate renal and hepatic function: dose adjustments may be needed in impairment.
• Avoid concomitant CNS depressants: increased risk of sedation and respiratory effects.
• Educate patients on constipation management: use laxatives or stool softeners as needed.
• Store at ambient temperature: keep in the original container, protect from moisture and heat.

Oxynorm can interact with a range of medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Benzodiazepines: combined use may cause profound respiratory depression.
• MAO‑Inhibitors: risk    ");

Moderate "); "); -  "); - "); - "); - "); - "); - "); - ",